Stryker Corporation - Investor Relations

Press Releases

12/21/2001	Stryker Announces Year-End Cash Dividend
12/21/2001	Stryker Announces $1 Billion Credit Facility
12/04/2001	Stryker Announces Management Changes
10/17/2001	Stryker Receives Humanitarian Device Exemption For OP-1; Stryker's Patented Bone Morphogenetic Protein (BMP) Is the First Approved in the U.S.
10/17/2001	Stryker Operating Results for Quarter Ended September 30, 2001
10/15/2001	Stryker Announces Management Changes
09/26/2001	Stryker Corporation to Host Conference Call on October 17, 2001
08/22/2001	Stryker Announces Management Changes
07/17/2001	Stryker Operating Results for Quarter Ended June 30, 2001
06/25/2001	Stryker Corporation to Host Conference Call on July 17, 2001
05/17/2001	Stryker Reports OP-1 Marketing Authorization in Europe
05/04/2001	Stryker Reports OP-1 Registration in Australia
04/18/2001	Stryker Operating Results For Quarter Ended March 31, 2001
03/26/2001	Stryker Corporation to Host Conference Call on April 18, 2001
02/16/2001	Stryker Reports OP-1 Receives Positive Opinion From Australian ADEC
02/15/2001	Stryker Corporation to Hold Analyst Meeting During The American Academy of Orthopaedic Surgeons
01/29/2001	Stryker Reports OP-1 PMA Receives Not-Approvable Letter From FDA
01/29/2001	Stryker Operating Results for Quarter and Year Ended December 31, 2000
01/05/2001	Stryker Corporation to Host Conference Call on January 29, 2001
01/02/2001	Stryker Reports OP-1 Receives Positive Opinion From European CPMP

Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. Designed and powered by Dow Jones Client Solutions. Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.